Business Development |
||
The Prism business model is structured and financed to facilitate aggressive acquisition, comprehensive development, and successful commercialization of acute care products that offer better solutions to healthcare providers and patients. Prism chooses product candidates by applying stringent, market-focused selection criteria and identifying unique, efficient development pathways shaped by medical need and market experience. On this basis, Prism is rapidly advancing a promising portfolio of acute care cardiovascular compounds. The Prism business development activities focus on the in-licensing and acquisition of hospital- based pharmaceutical products in late-stage development or already marketed within the US. Therapeutic areas of interest include, but are not limited to, cardiology, anesthesiology, surgery, and pain management. Prism has a successful track record in establishing lasting partnerships and maximizing its resources towards commercial success. While Prism is focused on building its US commercial business, it continues to seek strategic partnerships outside the US for out-licensing of existing compounds in the portfolio. For any business development related inquiries, please contact: Warren D. Cooper, MB, BS, BSc, MFPM |
 |
 |
1016 West Ninth Avenue, Suite 130 • King of Prussia, PA 19406 Toll-free: (888) 537-2085 • Local: (610) 265-7710 • Fax: (610) 265-7706 • Email: info@prismpharma.com |
Home | Legal | Contact Us
NEXTERONE is a trademark of Prism Pharmaceuticals, Inc. All other trademarks referenced are registered trademarks or trademarks of their respective owners.
© 2010 Prism Pharmaceuticals, Inc. All rights reserved.